Liquid biopsy could be groundbreaking in ovarian cancer (OC), where most patients are still diagnosed at advanced stages. We demonstrate a proof of concept for holographic label free distinction of OC cells from monocytes.
Cavina B., Giugliano G., Schiavo M., Pirone D., Miccio L., Memmolo P., et al. (2024). Optimizing label free circulating tumor cell detection for liquid biopsy in ovarian cancer. Optical Society of America [10.1364/DH.2024.W1A.2].
Optimizing label free circulating tumor cell detection for liquid biopsy in ovarian cancer
Cavina B.;Porcelli A. M.;Perrone A. M.;Gasparre G.;Kurelac I.
2024
Abstract
Liquid biopsy could be groundbreaking in ovarian cancer (OC), where most patients are still diagnosed at advanced stages. We demonstrate a proof of concept for holographic label free distinction of OC cells from monocytes.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
